Skene's Duct Cyst

Comprehensive Clinical Guide: Skene’s Duct Cysts

1. Introduction and Overview

Skene’s duct cysts, also known as paraurethral duct cysts, are rare, benign fluid-filled lesions originating from the paraurethral glands (Skene’s glands). These glands are the female homologue of the male prostate gland. Situated near the distal urethra, Skene’s glands typically drain into the vestibule via ducts located on either side of the urethral meatus.

When these ducts become obstructed—often due to infection, inflammation, or squamous metaplasia—the retained secretions lead to the formation of a cyst. While often asymptomatic, these cysts can present with significant morbidity, including dysuria, recurrent urinary tract infections (UTIs), dyspareunia, and obstructive voiding symptoms. Because of their anatomical proximity to the urethra and bladder neck, precise clinical assessment is mandatory to differentiate them from other pelvic floor pathologies.

2. Etiology and Pathophysiology

The formation of a Skene’s duct cyst is fundamentally a failure of ductal drainage. Understanding the underlying mechanism requires a look at the anatomy of the Skene’s gland complex.

The Mechanism of Obstruction

• Ductal Atresia/Obstruction: The primary driver. Obstruction can be caused by micro-calculi, inflammatory debris, or post-traumatic scarring.
• Squamous Metaplasia: Chronic irritation or hormonal fluctuations can lead to the transformation of the ductal epithelium, which may trap secretions.
• Infection: Chronic colonization by uropathogens (e.g., E. coli) creates an inflammatory response, leading to edema and eventual ductal closure.

Histopathology

Microscopically, these cysts are typically lined by pseudostratified columnar epithelium, though squamous metaplasia is common in chronic cases. The cyst wall is composed of fibrous connective tissue, and the fluid content is usually serous or mucoid, unless secondary infection has occurred, in which case the cyst transforms into a Skene’s duct abscess.

3. Clinical Staging and Presentation

While there is no universally standardized "staging" system for Skene’s duct cysts, clinicians typically categorize them by size and complication status.

Standard Presentation

Patients typically present in the reproductive or perimenopausal years. Key clinical findings include:
* Physical Exam: A soft, fluctuant, tender, or non-tender mass located at the 4 or 8 o’clock position relative to the urethral meatus.
* Voiding Symptoms: Obstructive patterns, such as a split stream, post-void dribbling, or a sensation of incomplete emptying.
* Sexual Dysfunction: Significant pain during intercourse (dyspareunia) due to the mass effect in the anterior vaginal wall.

4. Differential Diagnosis

Differentiating a Skene’s duct cyst from other periurethral masses is critical, as surgical approaches vary significantly.

• Urethral Diverticulum: The most important differential. Often presents with the "3 D’s" (dysuria, dyspareunia, post-void dribbling). MRI is the gold standard for differentiation.
• Gartner’s Duct Cyst: Usually located in the lateral vaginal wall, not restricted to the periurethral space.
• Bartholin’s Gland Cyst: Located at the 4 or 8 o’clock position of the introitus, not the urethral meatus.
• Urethral Caruncle: A small, red, fleshy lesion at the meatus; usually friable and painful, rather than a fluid-filled cystic mass.
• Epidermal Inclusion Cyst: Typically associated with previous episiotomy or trauma.

5. Diagnostic Testing Protocols

Diagnostic accuracy relies on a combination of physical examination and advanced imaging.

1. Physical Examination: Careful palpation of the anterior vaginal wall during a "milking" maneuver of the urethra can often express fluid from the duct, confirming the diagnosis.
2. Transperineal or Transvaginal Ultrasound (TVUS): Excellent for identifying the cystic nature of the mass and its relationship to the urethral lumen.
3. MRI (Pelvic): The diagnostic gold standard. It provides high-resolution imaging to determine if the cyst communicates with the urethra (suggesting a diverticulum) or is a discrete paraurethral lesion.
4. Urethroscopy: Used to rule out a urethral diverticulum and to assess the integrity of the urethral mucosa.

6. Surgical Management and Indications

Management is indicated if the cyst is symptomatic or enlarging.

• Marsupialization: The preferred approach for large or recurrent cysts. The cyst is opened, and the edges are sutured to the vaginal mucosa to prevent re-closure.
• Total Excision: Indicated if the cyst is firm, complex, or if there is suspicion of malignancy (though rare).
• Simple Aspiration: Generally discouraged as a primary treatment due to high recurrence rates (the cyst typically refills).

Risks and Side Effects of Intervention

• Urethral Injury: The most significant surgical risk, potentially leading to a urethro-vaginal fistula.
• Infection: Post-operative cellulitis or recurrence of abscess.
• Stress Urinary Incontinence (SUI): Rare, but can occur if the support structures of the bladder neck are disrupted during excision.
• Recurrence: If the entire glandular lining is not adequately addressed.

7. Long-term Prognosis and Follow-up

The prognosis for Skene’s duct cysts is excellent. Once successfully excised or marsupialized, recurrence is rare. Patients should be monitored for:
* Resolution of voiding symptoms.
* Healing of the vaginal mucosa.
* Absence of new cystic formation.

Routine follow-up at 6 weeks post-operatively is standard to ensure the surgical site has healed without fistula formation.

8. Massive FAQ Section

1. Is a Skene’s duct cyst a form of cancer?
No. Skene’s duct cysts are benign. However, any persistent mass in the pelvic region should be evaluated by a gynecologist or urologist to rule out malignancy, such as urethral carcinoma.

2. Can these cysts resolve on their own?
Small, asymptomatic cysts may remain stable for years. However, they do not typically "resolve" or disappear without intervention if they are already symptomatic.

3. What is the difference between a Skene’s duct cyst and a urethral diverticulum?
A Skene’s duct cyst is an obstruction of the paraurethral gland duct. A urethral diverticulum is an out-pouching of the urethra itself. MRI is the best tool to distinguish between the two.

4. Are these cysts related to STIs?
While infection can contribute to ductal obstruction, Skene’s duct cysts are not inherently sexually transmitted infections. However, they can be exacerbated by local inflammation.

5. How are they diagnosed if I have no symptoms?
They are often discovered during a routine pelvic examination as an incidental finding.

6. Does the cyst affect fertility?
No, Skene’s duct cysts do not interfere with fertility or the ability to conceive.

7. Is surgery the only treatment?
For symptomatic cysts, surgery (marsupialization or excision) is the standard of care. Antibiotics are only used if an abscess is present.

8. What happens if I leave it untreated?
If left untreated, a symptomatic cyst can lead to chronic pain, recurrent urinary tract infections, and, in severe cases, the formation of an abscess that may require emergency drainage.

9. Is the surgery painful?
Post-operative discomfort is common but generally managed well with standard analgesics. The procedure is typically performed under local, regional, or general anesthesia.

10. Can these cysts return after surgery?
Yes, recurrence is possible if the cyst wall is not completely removed or if the marsupialization site closes prematurely. However, with proper surgical technique, recurrence rates are very low.

9. Conclusion

Skene’s duct cysts represent a specialized area of urogynecological care. While they are benign and generally treatable, they require a methodical approach—ranging from accurate differential diagnosis via MRI to careful surgical excision to avoid iatrogenic urethral injury. By understanding the pathophysiology of the paraurethral glands, clinicians can provide effective, definitive care that restores quality of life and eliminates the morbidity associated with these pelvic masses.

Disclaimer: This guide is provided for educational and informational purposes for medical professionals. It does not replace professional clinical judgment. Always consult current urological guidelines and patient-specific factors before determining a treatment plan.